Income Statement (TTM)
Palisade Bio, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 0.00 | 0.00 | 0.00 | -100.00 | NaN | NaN | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | |||
| Cost Of Sales | |||||||
| Change (%) | |||||||
| % of Revenue | |||||||
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 0.00 | 0.00 | 0.00 | -100.00 | NaN | NaN | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | |||
| SG&A | 7 | 7 | 6 | 6 | 6 | 6 | 6 |
| Change (%) | -11.16 | -6.12 | 0.86 | -1.27 | 2.47 | -3.47 | |
| % of Revenue | 2,949.20 | 2,620.00 | 2,459.60 | 2,480.80 | |||
| R&D | 7 | 8 | 8 | 7 | 8 | 8 | 8 |
| Change (%) | 12.59 | 2.29 | -12.36 | 14.12 | 5.73 | 0.40 | |
| % of Revenue | 2,731.60 | 3,075.60 | 3,146.00 | 2,757.20 | |||
| OpEx | 14 | 14 | 14 | 13 | 14 | 15 | 14 |
| Change (%) | 0.26 | -1.58 | -6.56 | 6.83 | 4.30 | -1.27 | |
| % of Revenue | 5,680.80 | 5,695.60 | 5,605.60 | 5,238.00 | |||
| Operating Income | -14 | -14 | -14 | -13 | -14 | -15 | -14 |
| Change (%) | 0.27 | -1.61 | -6.68 | 8.91 | 4.30 | -1.27 | |
| % of Revenue | -5,580.80 | -5,595.60 | -5,505.60 | -5,138.00 | |||
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -16.67 | 40.00 | 7.14 | 6.67 | -6.25 | -13.33 | |
| % of Revenue | -4.80 | -4.00 | -5.60 | -6.00 | |||
| Net Income | -12 | -13 | -13 | -12 | -13 | -14 | -14 |
| Change (%) | 8.46 | -2.94 | -5.74 | 9.65 | 5.09 | -0.77 | |
| % of Revenue | -4,958.00 | -5,377.60 | -5,219.60 | -4,920.00 | |||
Source: Capital IQ
